WSM Stock Analysis: Williams-Sonoma | NYSE
Specialty Retail | NYSE, USA | Market Cap: 25.989m USD | 12M Return: 23.8% | US9699041011 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 265M
EPS Trend: -7.7%
Qual. Beats: 1
Rev. Trend: 84.1%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Williams-Sonoma, Inc. (NYSE: WSM) is a U.S.-based omni-channel specialty retailer offering a broad range of home-related products, including cookware, dining and entertaining items, furniture, bedding, lighting, rugs, decor, and personalized or made-to-order goods. It sells primarily under a portfolio of nine distinct brands-Williams Sonoma, Pottery Barn, Pottery Barn Kids, Pottery Barn Teen, West Elm, Williams Sonoma Home, Rejuvenation, Mark and Graham, and GreenRow-each targeting different customer segments and aesthetic preferences. Products reach consumers through e-commerce websites, direct-mail catalogs, and physical retail stores in the U.S. and internationally. The company was founded in 1956 and is headquartered in San Francisco, California.
As a large-cap consumer discretionary stock in the homefurnishing retail sub-industry, Williams-Sonomas performance is closely tied to housing turnover, real estate values, and broader consumer spending on the home. Its multi-brand, multi-channel model-combining owned e-commerce, catalog marketing, and branded retail stores-is a distinctive feature of its strategy, allowing it to capture customers across demographics and price points while maintaining direct relationships with end consumers rather than relying on third-party wholesale distribution.
- Housing market weakness pressures furniture demand across core brands
- Tariff and freight costs squeeze gross margins
- B2B segment drives double-digit growth offsetting retail softness
| Net Income: 1.22b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.23 > 0.02 and ΔFCF/TA 2.24 > 1.0 |
| NWC/Revenue: 11.18% < 20% (prev 10.01%; Δ 1.17% < -1%) |
| CFO/TA 0.28 > 3% & CFO 1.57b > Net Income 1.22b |
| Net Debt (551.2m) to EBITDA (1.85b): 0.30 < 3 |
| Current Ratio: 1.45 > 1.5 & < 3 |
| Outstanding Shares: last quarter (118.9m) vs 12m ago -3.54% < -2% |
| Gross Margin: 47.56% > 18% (prev 45.63%; Δ 1.94% > 0.5%) |
| Asset Turnover: 147.5% > 50% (prev 149.0%; Δ -1.42% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.16 (Total Current Assets 2.91b - Total Current Liabilities 2.00b) / Total Assets 5.69b |
| B: 0.29 (Retained Earnings 1.64b / Total Assets 5.69b) |
| C: 0.29 (EBIT TTM 1.62b / Avg Total Assets 5.50b) |
| D: 0.63 (Book Value of Equity 2.20b / Total Liabilities 3.48b) |
| Altman-Z'' = 4.63 = AA |
| DSRI: 1.29 (Receivables 156.7m/118.4m, Revenue 8.11b/7.91b) |
| GMI: 0.96 (GM 45.63% / 47.56%) |
| AQI: 0.91 (AQ_t 0.05 / AQ_t-1 0.06) |
| SGI: 1.03 (Revenue 8.11b / 7.91b) |
| TATA: -0.06 (NI 1.22b - CFO 1.57b) / TA 5.69b) |
| Beneish M = -2.87 (Cap -4..+1) = A |
As of November 21, 2026, the stock is trading at USD 210.70 with a total of 2,346,585 shares traded. Over the past week, the price has changed by -17.06%, over one month by -17.04%, over three months by -10.34% and over the past year by +23.77%.
Current recommended Stop Loss: 196.40 (which is 6.8% or 1.2 ATR below the current price).
Williams-Sonoma has received a consensus analysts rating of 3.78. Therefore, it is recommended to hold WSM.
- StrongBuy: 9
- Buy: 2
- Hold: 11
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 255.2 | 21.1% |
P/E Trailing = 18.4037
P/E Forward = 25.0
P/S = 3.2466
P/B = 14.3085
P/EG = 2.5969
Revenue TTM = 8.11b USD
EBIT TTM = 1.62b USD
EBITDA TTM = 1.85b USD
Long Term Debt = 1.33b USD (estimated: total debt 1.54b - short term 212.9m)
Short Term Debt = 212.9m USD (from shortTermDebt, last quarter)
Debt = 1.54b USD (from shortLongTermDebtTotal, last quarter) (leases 1.53b already included)
Net Debt = 551.2m USD (calculated: Debt 1.54b - CCE 991.6m)
Enterprise Value = 26.5b USD (26.0b + Debt 1.54b - CCE 991.6m)
Interest Coverage Ratio = unknown (Ebit TTM 1.62b / Interest Expense TTM 0.0)
EV/FCF = 20.22x (Enterprise Value 26.5b / FCF TTM 1.31b)
FCF Yield = 4.95% (FCF TTM 1.31b / Enterprise Value 26.5b)
FCF Margin = 16.18% (FCF TTM 1.31b / Revenue TTM 8.11b)
Net Margin = 15.04% (Net Income TTM 1.22b / Revenue TTM 8.11b)
Gross Margin = 47.56% ((Revenue TTM 8.11b - Cost of Revenue TTM 4.25b) / Revenue TTM)
Gross Margin QoQ = 47.65% (prev 51.64%)
Tobins Q-Ratio = 4.67 (Enterprise Value 26.5b / Total Assets 5.69b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 1.54b)
Taxrate = 25.18% (410.8m / 1.63b)
NOPAT = 1.21b (EBIT 1.62b * (1 - 25.18%))
Current Ratio = 1.45 (Total Current Assets 2.91b / Total Current Liabilities 2.00b)
Debt / Equity = 0.70 (Debt 1.54b / totalStockholderEquity, last quarter 2.20b)
Debt / EBITDA = 0.30 (Net Debt 551.2m / EBITDA 1.85b)
Debt / FCF = 0.42 (Net Debt 551.2m / FCF TTM 1.31b)
Total Stockholder Equity = 2.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 22.20% (Net Income 1.22b / Total Assets 5.69b)
RoE = 58.86% (Net Income TTM 1.22b / Total Stockholder Equity 2.07b)
RoCE = 47.57% (EBIT 1.62b / Capital Employed (Equity 2.07b + L.T.Debt 1.33b))
RoIC = 34.66% (NOPAT 1.21b / Invested Capital 3.49b)
WACC = 9.88% (E(26.0b)/V(27.5b) * Re(10.47%) + D(1.54b)/V(27.5b) * Rd(0.0%) * (1-Tc(0.25)))
Discount Rate = 10.47% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.98 | Cagr: -3.15%
[DCF] Terminal Value 73.17% ; FCFF base≈1.23b ; Y1≈1.41b ; Y5≈2.08b
[DCF] Fair Price = 204.0 (EV 24.6b - Net Debt 551.2m = Equity 24.0b / Shares 117.8m; r=9.88% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -7.72 | EPS CAGR: -0.93% | SUE: 1.70 | # QB: 1
Revenue Correlation: 84.11 | Revenue CAGR: 2.04% | SUE: -0.18 | # QB: 0
EPS current Quarter (2027-04-30): EPS=2.06 | Chg30d=-0.34% | Revisions=+0% | Analysts=6
EPS current Year (2027-01-31): EPS=10.12 | Chg30d=-0.42% | Revisions=+25% | GrowthEPS=+14.4% | GrowthRev=+6.2%
EPS next Year (2028-01-31): EPS=10.51 | Chg30d=+0.04% | Revisions=+0% | GrowthEPS=+3.9% | GrowthRev=+5.2%
[Analyst] Revisions Ratio: +12% (up=3, down=2)